234 related articles for article (PubMed ID: 1708944)
1. Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemia.
Jensen GS; Andrews EJ; Mant MJ; Vergidis R; Ledbetter JA; Pilarski LM
Am J Hematol; 1991 May; 37(1):20-30. PubMed ID: 1708944
[TBL] [Abstract][Full Text] [Related]
2. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Jensen GS; Mant MJ; Belch AJ; Berenson JR; Ruether BA; Pilarski LM
Blood; 1991 Aug; 78(3):711-9. PubMed ID: 1830500
[TBL] [Abstract][Full Text] [Related]
3. Transition in CD45 isoform expression during differentiation of normal and abnormal B cells.
Jensen GS; Poppema S; Mant MJ; Pilarski LM
Int Immunol; 1989; 1(3):229-36. PubMed ID: 2535062
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules.
Pilarski LM; Jensen GS
Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857
[TBL] [Abstract][Full Text] [Related]
5. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
Jensen GS; Mant MJ; Pilarski LM
Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
[TBL] [Abstract][Full Text] [Related]
6. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
[TBL] [Abstract][Full Text] [Related]
7. Prolonged expression of high molecular mass CD45RA isoform during the differentiation of human progenitor thymocytes to CD3+ cells in vitro.
Deans JP; Wilkins JA; Caixia S; Pruski E; Pilarski LM
J Immunol; 1991 Dec; 147(12):4060-8. PubMed ID: 1836475
[TBL] [Abstract][Full Text] [Related]
8. CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia.
Hunter ZR; Branagan AR; Manning R; Patterson CJ; Santos DD; Tournilhac O; Dorfman DM; Treon SP
Clin Lymphoma; 2005 Mar; 5(4):246-9. PubMed ID: 15794857
[TBL] [Abstract][Full Text] [Related]
9. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD45 isoforms by Epstein-Barr virus-transformed human B lymphocytes.
Marty LM; Caldwell CW; Feldbush TL
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):8-15. PubMed ID: 1370260
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of CD45 CD45R and CD45R0 monoclonal antibodies in modulating human B cell activation.
Deane DL; Harvey E; Steel CM
Clin Exp Immunol; 1991 Jan; 83(1):175-81. PubMed ID: 1703055
[TBL] [Abstract][Full Text] [Related]
12. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?
Kriangkum J; Taylor BJ; Reiman T; Belch AR; Pilarski LM
Clin Lymphoma; 2005 Mar; 5(4):217-9. PubMed ID: 15794851
[TBL] [Abstract][Full Text] [Related]
13. Relationship between CD45 antigen expression and putative stages of differentiation in B-cell malignancies.
Caldwell CW; Patterson WP
Am J Hematol; 1991 Feb; 36(2):111-5. PubMed ID: 1849347
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
San Miguel JF; Vidriales MB; Ocio E; Mateo G; Sánchez-Guijo F; Sánchez ML; Escribano L; Bárez A; Moro MJ; Hernández J; Aguilera C; Cuello R; García-Frade J; López R; Portero J; Orfao A
Semin Oncol; 2003 Apr; 30(2):187-95. PubMed ID: 12720134
[TBL] [Abstract][Full Text] [Related]
15. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations.
Treon SP; Kelliher A; Keele B; Frankel S; Emmanouilides C; Kimby E; Schlossman R; Mitsiades N; Mitsiades C; Preffer F; Anderson KC
Semin Oncol; 2003 Apr; 30(2):248-52. PubMed ID: 12720146
[TBL] [Abstract][Full Text] [Related]
16. Follicular lymphoma of compartmentalized small cleaved center cells and mantle zone lymphocytes. Evidence for a common derivation.
Carbone A; Gloghini A; Volpe R; Attadia V; Gattei V; Zagonel V; Pinto A
Am J Clin Pathol; 1992 Oct; 98(4):437-48. PubMed ID: 1384307
[TBL] [Abstract][Full Text] [Related]
17. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
[TBL] [Abstract][Full Text] [Related]
18. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.
Uckun FM; Gajl-Peczalska K; Myers DE; Jaszcz W; Haissig S; Ledbetter JA
Blood; 1990 Dec; 76(12):2449-56. PubMed ID: 1702326
[TBL] [Abstract][Full Text] [Related]
19. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.
Luque R; Brieva JA; Moreno A; Manzanal A; Escribano L; Villarrubia J; Velasco JL; López-Jiménez J; Cerveró C; Otero MJ; Martínez J; Bellas C; Roldán E
Clin Exp Immunol; 1998 Jun; 112(3):410-8. PubMed ID: 9649209
[TBL] [Abstract][Full Text] [Related]
20. The malignant clone in Waldenstrom's macroglobulinemia.
Kriangkum J; Taylor BJ; Mant MJ; Treon SP; Belch AR; Pilarski LM
Semin Oncol; 2003 Apr; 30(2):132-5. PubMed ID: 12720122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]